Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 13
Submit an article Journal homepage
250
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Improvement of therapy-induced myelodysplastic syndrome by infusion of autologous CD34-positive hematopoietic progenitor cells without chemotherapy

Anne-Sophie Alarya CNRS UMR8104, Institut Cochin, Université de Paris, INSERM U1016, Paris, France;b Hematology Laboratory, Cochin Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, FranceView further author information
,
Marguerite Vignona CNRS UMR8104, Institut Cochin, Université de Paris, INSERM U1016, Paris, France;c Hematology Department, Cochin Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, FranceView further author information
,
Raphael Carapitod Laboratoire d’ImmunoRhumatologie Moléculaire, plateforme GENOMAX, INSERM UMR_S 1109, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), LabEx TRANSPLANTEX, Université de Strasbourg, Strasbourg, FranceView further author information
,
Najeeb Halabie Stem Cell and Microenvironment Laboratory, Weill Cornell Medical College in Qatar, Education City, Qatar Foundation, Doha, QatarView further author information
,
Lise Willemsa CNRS UMR8104, Institut Cochin, Université de Paris, INSERM U1016, Paris, France;c Hematology Department, Cochin Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, FranceView further author information
,
Alexa Greena CNRS UMR8104, Institut Cochin, Université de Paris, INSERM U1016, Paris, France;b Hematology Laboratory, Cochin Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, FranceView further author information
,
Nicolas Chapuisa CNRS UMR8104, Institut Cochin, Université de Paris, INSERM U1016, Paris, France;b Hematology Laboratory, Cochin Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, FranceView further author information
,
Farhad Heshmatia CNRS UMR8104, Institut Cochin, Université de Paris, INSERM U1016, Paris, France;f Apheresis Unit, Cochin Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, FranceView further author information
,
Wendy Cuccuinig Hematology Laboratory, Saint Louis Hospital, AP-HP, Paris, FranceView further author information
,
Sophie Kaltenbachh Cytogenetic Unit, Necker Hospital, AP-HP, Paris, FranceView further author information
,
Isabelle Radford-Weissh Cytogenetic Unit, Necker Hospital, AP-HP, Paris, FranceView further author information
,
Olivier Kosmidera CNRS UMR8104, Institut Cochin, Université de Paris, INSERM U1016, Paris, France;c Hematology Department, Cochin Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, FranceView further author information
,
Didier Bouscarya CNRS UMR8104, Institut Cochin, Université de Paris, INSERM U1016, Paris, France;c Hematology Department, Cochin Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, FranceView further author information
,
Seiamak Bahramd Laboratoire d’ImmunoRhumatologie Moléculaire, plateforme GENOMAX, INSERM UMR_S 1109, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), LabEx TRANSPLANTEX, Université de Strasbourg, Strasbourg, FranceView further author information
,
Arash Rafiie Stem Cell and Microenvironment Laboratory, Weill Cornell Medical College in Qatar, Education City, Qatar Foundation, Doha, QatarView further author information
&
Jerome Tamburinia CNRS UMR8104, Institut Cochin, Université de Paris, INSERM U1016, Paris, France;c Hematology Department, Cochin Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, FranceCorrespondence[email protected] [email protected]
View further author information
 show all
Pages 3259-3262 | Received 15 Jun 2020, Accepted 27 Jul 2020, Published online: 28 Aug 2020

References

  • Gandolfi S, Prada CP, Richardson PG. How I treat the young patient with multiple myeloma. Blood. 2018;132(11):1114–1124.
  • Usmani SZ, Sawyer J, Rosenthal A, et al. Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma. Blood. 2013;121(23):4753–4757.
  • Sood R, Kamikubo Y, Liu P. Role of RUNX1 in hematological malignancies. Blood. 2017;129(15):2070–2082.
  • Gibson CJ, Lindsley RC, Tchekmedyian V, et al. Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma. J Cin Oncol. 2017;35(14):1598–1605.
  • Lindsley RC, Ebert BL. Molecular pathophysiology of myelodysplastic syndromes. Annu Rev Pathol. 2013;8:21–47.
  • Cutler C. Transplantation for therapy-related, TP53-mutated myelodysplastic syndrome – not because we can, but because we should. Haematologica. 2017;102(12):1970–1971.
  • Mailankody S, Pfeiffer RM, Kristinsson SY, et al. Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS). Blood. 2011;118(15):4086–4092.
  • Li L, Li M, Sun C, et al. Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk. Cancer Cell. 2011;20(5):591–605.
  • Sallman DA, List A. The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes. Blood. 2019;133(10):1039–1048.
  • Kröger N, Brand R, van Biezen A, for the Myelodysplastic Syndromes Subcommittee of The Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT), et al. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome. Bone Marrow Transplant. 2006;37(2):183–189.
  • Garfall AL, Maus MV, Hwang W-T, et al. Chimeric antigen receptor T cells against CD19 for multiple myeloma. N Engl J Med. 2015;373(11):1040–1047.
  • Raje N, Berdeja J, Lin Y, et al. Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma. N Engl J Med. 2019;380(18):1726–1737.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.